In patients with COVID-19, proinflammatory cytokines induced a redox-sensitive upregulation of SGLT2 expression in endothelial cells, which in turn promoted endothelial injury, senescence, platelet adhesion, aggregation, and thrombin generation [132]. This evidence concerns the gene SLC5A2 and COVID-19.